Dr. Pedram Razavi

Dr. Pedram Razavi, MD, PhD, is a board-certified medical oncologist and physician-scientist specializing in personalized care for patients with breast cancer. He practices within a multidisciplinary team that includes surgeons, radiation oncologists, and nurses, working collaboratively to deliver comprehensive care to patients and their families. His dual training as a clinician and scientist informs both his patient-centered approach and his commitment to advancing the field through rigorous research.

Dr. Razavi's research centers on cancer genomics, with a focus on understanding the molecular mechanisms underlying treatment resistance and response. A central area of his work is the development of liquid biopsy assays, specifically circulating tumor DNA assays, that detect tumor genomic changes from blood samples. These tools have the potential to monitor disease extent and heterogeneity, predict individual responses to therapy, and identify early-stage disease or minimal residual disease with high precision.

His broader scientific goal is to translate findings from genomic studies into practical, actionable treatment strategies for people with breast cancer. By developing molecular biomarkers to guide precision medicine, Dr. Razavi aims to move beyond one-size-fits-all approaches and tailor therapies to the unique biology of each patient's cancer. Through his combined commitment to clinical care and scientific discovery, he continues to work toward improving outcomes for individuals facing breast cancer.